Xtrackers MSCI Global SDG 3 Good Health UCITS ETFXtrackers MSCI Global SDG 3 Good Health UCITS ETFXtrackers MSCI Global SDG 3 Good Health UCITS ETF

Xtrackers MSCI Global SDG 3 Good Health UCITS ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪24.53 M‬EUR
Fund flows (1Y)
‪−114.76 M‬EUR
Dividend yield (indicated)
Discount/Premium to NAV
0.4%
Shares outstanding
‪715.42 K‬
Expense ratio
0.35%

About Xtrackers MSCI Global SDG 3 Good Health UCITS ETF


Brand
Xtrackers
Home page
Inception date
Jan 18, 2023
Structure
Irish VCIC
Index tracked
MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
DWS Investment SA
ISIN
IE00036F4K40
Functions as an open-end investment fund

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of June 11, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.95%
Health Technology97.44%
Consumer Non-Durables2.19%
Non-Energy Minerals0.11%
Health Services0.08%
Producer Manufacturing0.07%
Distribution Services0.04%
Retail Trade0.02%
Bonds, Cash & Other0.05%
Cash0.05%
Stock breakdown by region
1%72%21%4%
North America72.28%
Europe21.53%
Asia4.29%
Oceania1.91%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


XDG3 invests in stocks. The fund's major sectors are Health Technology, with 97.44% stocks, and Consumer Non-Durables, with 2.19% of the basket. The assets are mostly located in the North America region.
XDG3 top holdings are Novo Nordisk A/S Class B and Eli Lilly and Company, occupying 5.08% and 4.77% of the portfolio correspondingly.
XDG3 assets under management is ‪24.53 M‬ EUR. It's fallen 20.69% over the last month.
XDG3 fund flows account for ‪−114.76 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, XDG3 doesn't pay dividends to its holders.
XDG3 shares are issued by Deutsche Bank AG under the brand Xtrackers. The ETF was launched on Jan 18, 2023, and its management style is Passive.
XDG3 expense ratio is 0.35% meaning you'd have to pay 0.35% of your investment to help manage the fund.
XDG3 follows the MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
XDG3 invests in stocks.
XDG3 price has fallen by −0.39% over the last month, and its yearly performance shows a −7.01% decrease. See more dynamics on XDG3 price chart.
NAV returns, another gauge of an ETF dynamics, showed a −7.28% decrease in three-month performance and has decreased by −6.67% in a year.
XDG3 trades at a premium (0.42%) meaning the ETF is trading at a higher price than the calculated NAV.